A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.

about

A Survey Study of Gastroenterologists' Attitudes and Barriers Toward Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease.

Item

http://www.wikidata.org/entity/Q47258474

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@en

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@nl

type

Item

label

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@en

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@nl

prefLabel

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@en

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@nl

P1476

A Survey Study of Gastroentero ...... in Inflammatory Bowel Disease.

@en

P2093

Adam S Cheifetz

http://www.w3.org/2001/XMLSchema#string

Corey A Siegel

http://www.w3.org/2001/XMLSchema#string

Joseph D Feuerstein

http://www.w3.org/2001/XMLSchema#string

Konstantinos Papamichael

http://www.w3.org/2001/XMLSchema#string

Laurie B Grossberg

http://www.w3.org/2001/XMLSchema#string

Thomas A Ullman

http://www.w3.org/2001/XMLSchema#string

P2860

Review article: loss of response to anti-TNF treatments in Crohn's disease.

Use of anti-TNF drug levels to optimise patient management.

Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn's Disease.

Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Bowel Disease.

Efficacy and Safety Profile of Anti-tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn's Disease: A Network Meta-analysis of Indirect Comparisons.

Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis.

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases.

Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.

Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study.

P304

191-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/IBD/IZX023

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29272486

http://www.w3.org/2001/XMLSchema#string

P921

gastroenterology

TNF inhibitor